首页> 美国政府科技报告 >Generic Therapy after Exposure to Biological Warfare Agents: Validation of an in Vitro Dendritic Cell Culture System
【24h】

Generic Therapy after Exposure to Biological Warfare Agents: Validation of an in Vitro Dendritic Cell Culture System

机译:暴露于生物战剂后的通用疗法:体外树突状细胞培养系统的验证

获取原文

摘要

The threat of the use of biological weapons, including bacteria, has increased. Bacterial resistance to antibiotics increasingly becomes a problem. Vaccination of military personnel against biothreat agents may be an option, however there is a broad range of biothreat agents, which may become even broader as a result of genetic engineering. Moreover, vaccination against multiple agents may cause undesired effects. A more generic approach to prevent the effects of a broad spectrum of bacteria via immunomodulation seems more effective. To be able to study the development of immune responses against bio- threat bacteria to select potential broad-spectrum therapeutics, an in vitro culture system of dendritic cells was chosen, since this cell type plays a central role in the development of immune responses. A dendritic cell culture system was validated using model compounds of which the effects on dendritic cells are known (LPS, IFN-gamma, PGE2). The system was analyzed by measuring expression of surface markers on dendritic cells as well as cytokine production by dendritic cells and polarized T cells. All responses were in agreement with published literature in peer-reviewed journals.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号